SEARCH

SEARCH BY CITATION

References

  • 1
    Shiode N, Kato M, Nakayama K, Shinohara K, Kurokawa J, et al.: Effect of adenosine triphosphate on human coronary circulation. Intern Med 1998; 37: 818825.
  • 2
    Miyagawa M, Kumano S, Sekiya M, Watanabe K, Akutzu H, et al.: Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol 1995; 26: 11961201.
  • 3
    Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, et al.: Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 1997; 38: 577581.
  • 4
    Teragawa H, Yamagata T, Kato M, Hiraga M, Matsuura H, et al.: Assessment of the severity of coronary artery stenosis by the ratio of the regional washout rate determined by adenosine triphosphate stress Tl-201 SPECT. J Nucl Cardiol 1999; 6: 324331.
  • 5
    Bravo N, Gimenez M, Mejia S, Garcia-Velloso MJ, Coma-Canella I: Prognostic value of myocardial perfusion imaging with adenosine triphosphate. J Nucl Cardiol 2002; 9: 395401.
  • 6
    Yasue H, Kugiyama K: Coronary spasm: clinical features and pathogenesis. Intern Med 1997; 36: 760765.
  • 7
    Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, et al.: Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004; 11: 414423.
  • 8
    Teragawa H, Fukuda Y, Matsuda K, Hirao H, Higashi Y, et al.: Myocardial bridging increases the risk of coronary spasm. Clin Cardiol 2003; 26: 377383.
  • 9
    Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G: The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000; 118: 16901695.
  • 10
    Sueda S, Kohno H, Fukuda H, Uraoka T: Coronary flow reserve in patients with vasospastic angina: correlation between coronary flow reserve and age or duration of angina. Coron Artery Dis 2003; 14: 423429.
  • 11
    Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, et al.: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 12221230.
  • 12
    Waters DD, Szlachcic J, Bourassa MG, Scholl JM, Theroux P: Exercise testing in patients with variant angina: results, correlation with clinical and angiographic features and prognostic significance. Circulation 1982; 65: 265274.
  • 13
    Kugiyama K, Yasue H, Okumura K, Minoda K, Takaoka K, et al.: Simultaneous multivessel coronary artery spasm demonstrated by quantitative analysis of thallium-201 single photon emission computed tomography. Am J Cardiol 1987; 60: 10091014.
  • 14
    Falstie-Jensen N, Engby B, Rasmussen K, Bagger JP, Thuesen L, et al.: Vasospastic angina assessed by hyperventilation-thallium-201 myocardial scintigraphy. Acta Med Scand 1987; 222: 133136.
  • 15
    Aoki M, Koyanagi S, Sakai K, Irie T, Takeshita A, et al.: Exercise-induced silent myocardial ischemia in patients with vasospastic angina. Am Heart J 1990; 119: 551556.
  • 16
    Sueda S, Mineoi K, Kondou T, Yano K, Ochi T, et al.: Usefulness of thallium-201 myocardial scintigraphy during hyperventilation and accelerated exercise test in patients with vasospastic angina and nearly normal coronary artery. J Cardiol 1998; 31: 207213.
  • 17
    Fujita H, Yamabe H, Yokoyama M: Dipyridamole-induced reversible thallium-201 defect in patients with vasospastic angina and nearly normal coronary arteries. Clin Cardiol 2000; 23: 2430.
  • 18
    Ito A, Fukumoto Y, Shimokawa H: Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480485.
  • 19
    Takeishi Y, Takahashi N, Fujiwara S, Atsumi H, Takahashi K, et al.: Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate. J Nucl Med 1998; 39: 582586.
  • 20
    Fragasso G, Rossetti E, Dosio F, Gianolli L, Pizzetti G, et al.: High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J 1996; 17: 14821487.
  • 21
    Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, et al.: Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996; 94: 32323238.
  • 22
    Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, et al.: Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997; 30: 14721477.
  • 23
    Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, et al.: Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000; 35: 16541660.
  • 24
    Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, et al.: Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. J Am Coll Cardiol 1996; 27: 304310.
  • 25
    Zeiher AM, Krause T, Schachinger V, Minners J, Moser E: Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995; 91: 23452352.
  • 26
    Akasaka T, Yoshida K, Hozumi T, Takagi T, Kawamoto T, et al.: Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina. Am J Cardiol 1997; 80: 705710.